The global rheumatic disorders drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Rheumatic disorders are a wide range of conditions that are characterized by chronic pain, with some of the most common conditions being osteoarthritis (OA) and rheumatoid arthritis (RA), and it is estimated that about one in four adults in America is diagnosed with a rheumatic disorder. The rheumatic disorder therapy area is multi-disciplinary and encompasses conditions that affect joints, connective tissue, ligaments, tendons, cartilage, bone and muscle and which are characterized by chronic pain and a consequent reduction in function and motion.
The majority of rheumatic disorders are treated using largely genericized pain management drugs. The incidence of many indications within the rheumatic disorders therapy area continues to rise and as the global population ages prevalence will increase which is a key driver of market growth. The market growth will also be driven by the entry of new products to the market, with two drug classes, in particular, driving the strong market growth.
To Request a Sample of our Report on Global Rheumatic Disorders Drug Market: https://www.omrglobal.com/request-sample/rheumatic-disorders-drug-market
The global rheumatic disorders drug market analysis includes some of the key market players such as AbbVie Inc, Amgen Inc., Johnson & Johnson Services Inc., Novartis International AG, among others. To maintain a strong position in the market, the market players are adopting various strategic moves, such as product launches, partnerships and collaborations, and mergers and acquisitions. For instance, in November 2021, Sandoz Egypt, in collaboration with the Egyptian Orthopedic Association (EOA), has announced the launch of a new non-steroidal anti-inflammatory drug (NSAID from Sandoz), etoricoxib, for the treatment of arthritis and chronic rheumatic disorders symptoms.
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
· Segment Covered
· Regions Covered- Globally
· Competitive Landscape: AbbVie Inc, Amgen Inc., Johnson & Johnson Services Inc., Novartis International AG, among others.
(Get 15% Discount on Buying this Report)
A full Report of Global Rheumatic Disorders Drug Market is Available at: https://www.omrglobal.com/industry-reports/rheumatic-disorders-drug-market
Global Rheumatic Disorders Drug Market Report Segmentation
By Route of Administration
• Oral
• Parenteral
By Drug Class
• Disease-modifying Anti-rheumatic Drugs (DMARDs)
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
• Corticosteroids
• Uric Acid Drugs
• Others
Global Rheumatic Disorders Drug Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
